What is Polyoxyethylene (600) Monoricinoleate?
Polyoxyethylene (600) Monoricinoleate is a non-ionic surfactant created through the chemical combination of castor oil derivatives with polyethylene glycol (PEG) chains containing approximately 600 ethylene oxide units. The resulting compound is a surface-active agent designed to reduce interfacial tension between incompatible substances. Its CAS number is 977137-78-2. The molecule functions by positioning hydrophobic (water-repelling) and hydrophilic (water-attracting) regions strategically, enabling it to stabilize emulsions and improve the solubility of various food ingredients.
Common Uses
Polyoxyethylene (600) Monoricinoleate is utilized in food manufacturing as an emulsifier, solubilizer, and dispersing agent. Its primary applications include:
- Beverage formulations where oil-based flavoring compounds need to be evenly distributed in water-based systems
- Bakery products to improve texture and moisture retention
- Dairy-based products to enhance stability and prevent ingredient separation
- Confectionery items to achieve desired viscosity and consistency
- Nutritional supplements and fortified food products where fat-soluble vitamins or nutrients require uniform distribution
The additive's emulsifying properties allow manufacturers to reduce reliance on other stabilizing agents and create more homogeneous final products with improved shelf stability.
Safety Assessment
Polyoxyethylene (600) Monoricinoleate has not been formally approved by the FDA as Generally Recognized as Safe (GRAS). However, this status reflects the lack of formal GRAS petition submission rather than any established safety concerns. According to FDA records, there have been zero adverse events reported and zero recalls associated with this additive, suggesting it has not generated documented safety issues in marketed food products.
As a polyoxyethylene compound, it shares structural similarity with other PEG-based food additives that have undergone safety evaluation. The parent compounds—castor oil and polyethylene glycol—have extensive historical use and generally accepted safety profiles in food applications. The ricinoleic acid component, derived from castor oil, has been used in food and cosmetic applications for decades.
The non-ionic nature of this surfactant suggests lower potential for skin irritation or systemic toxicity compared to some ionic alternatives. Its large molecular weight and complex structure indicate minimal likelihood of complete absorption in the gastrointestinal tract, with most material expected to transit through the digestive system largely unchanged.
Regulatory Status
In the United States, Polyoxyethylene (600) Monoricinoleate does not hold FDA GRAS status, meaning it is not classified as Generally Recognized as Safe for direct food use without pre-market approval. This does not indicate the additive is unsafe; rather, it has not completed the formal petition and review process required for GRAS designation.
The additive may be used in foods under FDA regulations if it meets requirements as a food additive, subject to established limitations and specifications. Manufacturers using this ingredient must ensure compliance with Code of Federal Regulations Title 21 requirements for food additives.
International regulatory approaches may vary, with some regions permitting use under different approval frameworks or with different naming conventions. The absence of regulatory approval in one jurisdiction does not necessarily indicate restriction in others.
Key Studies
Limited published scientific literature specifically addresses Polyoxyethylene (600) Monoricinoleate toxicology. However, safety data on structurally similar polyoxyethylene compounds and castor oil derivatives supports the general safety profile of this class of surfactants at typical food additive use levels.
Broader research on polyoxyethylene compounds demonstrates that these materials are generally poorly absorbed through the gastrointestinal tract and are rapidly excreted. Studies on related PEG-based surfactants indicate minimal accumulation in body tissues and low systemic toxicity potential at food-relevant concentrations.
The zero adverse event reports and zero recalls in FDA records over the period of its use in marketed products suggest adequate real-world safety performance, though this represents post-market surveillance data rather than controlled clinical trials.